Gardiner Healthcare Acquisition Corp.
Status: Liquidated
U=S+W
W=S@11.50
| IPO Proceeds, $M | $86.25M |
|---|---|
| IPO Date | Dec 22, 2021 |
| CEO | Marc F. Pelletier |
| Left Lead | Chardan |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 12 + 6 + 6 |
| IPO Sector |
Healthcare
High-growth healthcare businesses |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Jun 20, 2023 |
| Closing Date | Dec 18, 2023 |
GDNR
GDNRU
GDNRW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Gardiner Healthcare Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 25 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Marc F. Pelletier | 50 | Chairman and Chief Executive Officer |
| Paul R. McGuirk | 69 | Executive Vice President, Chief Development Officer and Director |
| Frank C. Sciavolino | 80 | Director |
| James P. Linton | 58 | Director |
| Thomas F. Ryan, Jr. | 43 | Director |
| Matthew Rossen | 44 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Chardan | BR | 7,500,000 | units |
| 7,500,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| BCMA | 3.50 | % |
Sign in to view more advisor data.